The $622 Million Footnote Behind DocuSign's Record Buyback

DocuSign's product exists to make a signed document binding. The document that now binds its stock price sits in a different drawer: the cash-flow statement from the fiscal year ended January 31, 2026. There, one line — stock-based compensation of $622 million — is larger than the $309.1 million the company reported as GAAP net income for the same year. The compensation bill was roughly double the profit.

That is not an accusation. It is the door. DocuSign trades at about $64, a market value near $12 billion, after a year in which the shares were cut almost in half and then clawed most of the way back. The recovery runs on a sentence the company wants investors to believe: it is no longer just an e-signature company but an "AI-native" agreement platform, generating record cash and returning billions to shareholders. The $622 million line resists that sentence the way a contract with previously missed terms resists a quick signature. Follow it, and the bull story turns out to be true in important ways — and thinner in the ways the market most cares about.

A stock that never stopped being a takeover rumor

Start with the price, because it explains why the market is paying attention at all. In December 2023 the Wall Street Journal reported DocuSign had hired advisers to explore a sale; the shares spiked. By January 2024, Bain Capital and Hellman & Friedman were named the final bidders in an auction for a company valued around $12.5 billion. In February 2024 the talks collapsed over price, DocuSign announced a restructuring, and it committed to staying independent. The failed leveraged buyout left behind a permanent "buy me" sign that still moves the stock on any whisper — a Betaville alert renewed buyout speculation in October 2025.

What followed was a slow punishment for stalled growth. The stock spent 2025 sliding, so that by February 2026 it was near $44, down about 50% from its prior high in a year. Then came the pattern that repeats every quarter: beat the small numbers, disappoint on the narrative. On June 4, 2026, DocuSign beat revenue and profit estimates for its fiscal first quarter, and the stock fell roughly 5% after hours anyway because the full-year guidance merely met, not exceeded, expectations. The selloff extended into a five-day, 19% losing streak that took the shares near their 52-week low around $40.

The rebound since June has been just as fast — up more than 30% over the past four months, including a late-August pop when Google announced DocuSign's Intelligent Agreement Management (IAM) platform would integrate with Gemini Enterprise for Legal. But here is the tell: the stock now trades above the median analyst price target of roughly $55 and above BofA's $58 target, which carries an Underperform rating. The consensus, in other words, is that the market has already paid for the reacceleration story it has not yet received.

Eight percent growth, wrapped in an AI ribbon

Strip the AI language and look at the meter. Fiscal 2026 revenue was $3.2 billion, up 8%. The company's own guidance for fiscal 2027 is about $3.5 billion, another 8% to 9%, with annual recurring revenue (ARR) growth guided to a mid-single-band of 8.25% to 8.75%.

The growth that exists is concentrated in a thin layer on top of a mature base. IAM — the AI-driven agreement platform management calls the future — was 2.3% of ARR a year ago, 10.8% at the end of fiscal 2026, and 12.6% as of April 30, 2026. Management says 40,000 customers are investing in the platform, an impressive clause until you set it against nearly 1.9 million total customers; the AI layer is roughly 13% of the recurring revenue, and the other 87% is the eSignature base, where dollar-based net retention was about 102% in late fiscal 2026. Net retention above 100% means customers are spending slightly more, not that the base is expanding briskly. This is what an eight-percent grower looks like even with a popular AI add-on: real, incremental, and nowhere near the parabolic reacceleration the multiple seems to be paying for.

The cash the profit doesn't explain

Now the line that binds the story together. In fiscal 2026 DocuSign generated $1.165 billion of operating cash flow, nearly four times its $309.1 million of GAAP net income. That gap is the whole ballgame, and the reconciliation is mostly one line.

The dominant non-cash add-back is the $622 million of stock-based compensation — the cost of paying employees in equity, which the cash-flow statement adds back because it never crosses a bank account. Add in customers paying roughly a year up front (deferred revenue) and depreciation, and the cash automatically towers over the profit. This is why adjusted earnings look so different from reported ones: non-GAAP diluted EPS was $3.84 in fiscal 2026, about 2.6 times the GAAP EPS of $1.48. On an adjusted basis the company "earned" about $800 million; on a GAAP basis it kept $309 million. The difference is, overwhelmingly, the compensation bill.

Now follow the same dollar into the financing section. Fiscal 2026 share repurchases totaled $869.1 million, a record, and in March the board added $2.0 billion to the authorization, leaving $2.6 billion available. This is the headline "capital returns" story. But set the repurchases next to the compensation program: $869 million of buybacks against a $622 million equity-compensation expense plus the cash DocuSign pays the taxman when employee awards vest. In round terms, the celebrated buyback is buying back the very shares the compensation plan hands out; it is recycling dilution, not mostly returning surplus cash.

The per-share arithmetic still works in shareholders' favor — the count does shrink. Diluted shares fell from about 209 million in fiscal 2026 to about 196 million in the quarter ended April 30, 2026, and management guides to 190 to 195 million for fiscal 2027. Net of the treadmill, that is a real several-percent annual tailwind to earnings per share. But it also means the "billions returned to shareholders" headline overstates the net return by roughly the size of the compensation program, and it means EPS growth is partly manufactured by the denominator rather than by the top line.

There is one more trap in this history, and it is the one that fooled the most people. Fiscal 2025 GAAP earnings per share was $5.08 — until you notice that the year's GAAP "profit" of $1.07 billion came from a roughly $1.0 billion one-time release of a deferred tax asset valuation allowance, a non-cash accounting credit that took the tax line to an $820 million benefit. When that credit did not repeat, fiscal 2026 GAAP EPS "collapsed" to $1.48 even though operating cash flow actually rose from $1.02 billion to $1.17 billion. The underlying business barely changed; the accounting headline bounced off a tax-paper one-off. Anyone who anchored to the $5.08 figure got a false sell signal, and anyone who anchored to it the other direction misread the trend.

For the record: nothing in the gap above is hidden or improper. The compensation expense, the tax benefit, the buybacks, and the share counts all sit in audited filings in plain sight. By the evidence ladder this is a Level Two observation — a discrepancy made visible by comparing two statements the company publishes itself — not a suspicion of concealment. The accounting is clean. What is not clean is the gap between the adjusted-earnings story investors trade on and the GAAP picture that includes the real cost of the equity.

What is priced in

Here is the invoice. At $64, on late-August market data, DocuSign sells for about 3.7 times trailing revenue, roughly 39 times trailing GAAP earnings, and (by the midpoint of fiscal 2027 guidance) a bit under 15 times the adjusted earnings the guidance implies. On the adjusted lens, that is a reasonably-priced eight-percent grower with a big buyback; on the GAAP lens, it is a rich stock against roughly $1.50 of reported earnings per share. Adobe trades at about 16 times GAAP earnings and Dropbox about 18 times — which is to say the market values DocuSign's reported earnings at a premium to comparable document and storage software, while its adjusted multiple is in line. The entire question of whether this stock is cheap or expensive turns on which earnings number you are willing to accept.

The next settling event is Thursday, September 3, after the close, when DocuSign reports its fiscal second quarter. The company already told you the shape: revenue guided to $865 million to $869 million, about 8% growth year over year. The June quarter taught the market that beating that number by a hair will not re-rate the stock unless the reacceleration story visibly advances. Watch the ARR growth rate at the margin, whether IAM's share of ARR climbs from 12.6%, the pace of buybacks under the swollen authorization, and whether management nudges the full-year number.

The three cases, sized for a shareholder: if IAM attach finally bends the growth curve toward double digits, the stock is cheap and the buyback compounds the recovery. If growth holds at eight percent, the buyback and margin expansion keep the adjusted earnings compounding at a low-teens clip, and $64 is roughly fair — the return comes from the machine, not from the multiple. If growth slips toward six percent while the buyback absorbs all available cash and the takeover chatter finally quiets, the stock sits above its own Street targets with the least cushion of the three. None of those cases requires hidden math to work. It only requires the willingness to read, before you sign, the line the compensation plan wrote into the cash-flow statement.